Lenvervimab
Lenvervimab
Lenvervimab (pronounced len-ver-vi-mab) is a type of monoclonal antibody used in the treatment of various diseases.
Etymology
The term "Lenvervimab" is derived from the International Nonproprietary Names (INN) system, where "mab" stands for monoclonal antibody. The prefix "Lenver" is a unique identifier for this specific antibody.
Usage
Lenvervimab is used in the treatment of diseases where the immune system's response is a part of the disease process. As a monoclonal antibody, Lenvervimab is designed to bind to specific cells or proteins, which can stimulate the patient's immune system to attack those cells.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Immune System: The body's defense against infectious organisms and other invaders.
- Protein: A molecule composed of polymers of amino acids joined together by peptide bonds.
- International Nonproprietary Names: The official nonproprietary or generic names given to a pharmaceutical substance, as designated by the World Health Organization (WHO).
External links
- Medical encyclopedia article on Lenvervimab
- Wikipedia's article - Lenvervimab
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski